IKERVIS Eye drops, emulsion Ref.[6693]
Active ingredients: Ciclosporin

Source: European Medicines Agency (EU) |  Revision Year: 2017 |  Publisher: SANTEN Oy, Niittyhaankatu 20, 33720, Tampere, Finland

Product name and form

IKERVIS 1 mg/mL eye drops, emulsion.

Pharmaceutical Form

Eye drops, emulsion.

Milky white emulsion.

Qualitative and quantitative composition

One mL of emulsion contains 1 mg of ciclosporin.

Excipient with known effect: One mL of emulsion contains 0.05 mg cetalkonium chloride (see section 4.4).

For the full list of excipients, see section 6.1.

Active Ingredient

Ciclosporin (also known as ciclosporin A) is a cyclic polypeptide immunomodulator with immunosuppressant properties. It has been shown to prolong survival of allogeneic transplants in animals and significantly improved graft survival in all types of solid organ transplantation in man. Ciclosporin has also been shown to have an anti-inflammatory effect.

List of Excipients

Medium-chain triglycerides
Cetalkonium chloride
Poloxamer 188
Sodium hydroxide (to adjust pH)
Water for injections

Pack sizes and marketing

IKERVIS is supplied in 0.3 mL single-dose, low-density polyethylene (LDPE) containers presented in a sealed laminate aluminium pouch.

One pouch contains five single-dose containers.

Pack sizes: 30 and 90 single-dose containers.

Not all pack sizes may be marketed.

Marketing authorization holder

SANTEN Oy, Niittyhaankatu 20, 33720, Tampere, Finland

Marketing authorization dates and numbers



Date of first authorisation: 19 March 2015


Austria, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Lithuania, Netherlands, Poland, Romania, Singapore, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.